Where can i get intravenous vitamin c treatment

Error Email field is required. Error Include a valid email address. To provide you with the most relevant and helpful information and to understand which information is beneficial, we may combine your e-mail and website usage information with other information we have about you. If we combine this information with your PHI, we will treat all of that information as PHI, and will only use or disclose that information as set forth in our notice of privacy practices.

You may opt-out of e-mail communications at any time by clicking on the Unsubscribe link in the e-mail. Our Housecall e-newsletter will keep you up-to-date on the latest health information. Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission.

Mayo Clinic does not endorse any of the third party products and services advertised. A single copy of these materials may be reprinted for noncommercial personal use only. This content does not have an English version. This content does not have an Arabic version. See more conditions. Request Appointment. High-dose vitamin C: Can it kill cancer cells? Products and services. I've heard that vitamin C might be an alternative cancer treatment.

What can you tell me about it? Answer From Karthik Giridhar, M. Thank you for Subscribing Our Housecall e-newsletter will keep you up-to-date on the latest health information. Remember, your body can only absorb so much Vitamin C orally. Higher doses will likely cause problems on your gastrointestinal tract. IV therapy allows the body to benefit from higher doses of the vitamin without adverse effects.

Our team is committed to creating a healing and stress-free environment where you can relax during your treatment and focus on feeling better. Do you have questions about Vitamin C IV treatments? The practitioners here at Urban Wellness Group are happy to help. Give us a call at or contact us online today. Collagen Production Vitamin C plays an important role in the maintenance of collagen throughout your body.

Anti-Cancer Properties When used alongside traditional chemotherapy treatments, studies show Vitamin C can effectively assist in the treatment of many types of cancer by: Reducing toxicity levels in your body Vitamin C can help you tolerate higher doses of chemotherapy. Fighting off cancer cells Vitamin C does more than just protect your body-- it can even help you fight cancer.

Antihistamine Effects Suffer from spring-time allergies? Antioxidant Effects Oxidation is a normal chemical process that happens in your body. Expect plenty of time to get the care you need and have all your questions answered. Name: Phone: Email: Message:. Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs. Gao, P. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12, — Gillberg, L.

Vitamin C — A new player in regulation of the cancer epigenome. Cancer Biol. Goncalves, T. Delta-Aminolevulinate dehydratase activity and oxidative stress during melphalan and cyclophosphamide-BCNU-etoposide CBV conditioning regimens in autologous bone marrow transplantation patients.

Gonzalez, M. Schedule dependence in cancer therapy: intravenous vitamin C and the systemic saturation hypothesis. Grasso, C. Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model.

Guemouri, L. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Gunes-Bayir, A. Palliative vitamin C application in patients with radiotherapy-resistant bone metastases: a retrospective study. Cancer 67, — Gupta, A. Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients. Cell Longev. Gustafson, C. Epigenetic reprogramming of melanoma cells by vitamin C treatment.

Haffner, M. Oncotarget 2, — Harris, H. Vitamin C and survival among women with breast cancer: a meta-analysis. J Cancer 50, — Herst, P. Hirota, K. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Hirsila, M. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. Hoffer, L. Phase I clinical trial of i. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a Phase I-II clinical trial.

PLoS One e Hosokawa, Y. Effects of Xray irradiation in combination with ascorbic acid on tumor control. Huijskens, M. Ascorbic acid serum levels are reduced in patients with hematological malignancies. Results Immunol. Hunnisett, A. Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Trace Elem. Jonas, C. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients.

Jozwiak, P. Expression of hypoxia inducible factor 1alpha and 2alpha and its association with vitamin C level in thyroid lesions. Kahn, S. Fictitious hyperglycemia: point-of-care glucose measurement is inaccurate during high-dose vitamin C infusion for burn shock resuscitation.

Burn Care Res.. Kalita, S. Indian J. Kawada, H. Tokai J. Khanzode, S. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Kiziltan, H. Ascorbic-acid treatment for progressive bone metastases after radiotherapy: a pilot study.

Health Med. Klose, R. JmjC-domain-containing proteins and histone demethylation. Koivunen, P. Catalytic properties of the asparaginyl hydroxylase FIH in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. Kroeze, L.

Kudo, Y. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. Kuiper, C. Increased tumor ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer.

Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Ascorbate as a co-factor for Fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Lawenda, B. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Cancer Inst. Lawton, J. Acute oxalate nephropathy after massive ascorbic acid administration. Lee, J. Levine, M. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Lian, C. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

Cell , — Liu, M. Low, F. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Lykkesfeldt, J. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Ma, Y. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.

A convenient method for measuring blood ascorbate concentrations in patients receiving high-dose intravenous ascorbate. Coll Nutr. Mahdavi, R. Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients.

Mamede, A. Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line WiDr : in vitro and in vivo studies. Cancer 64, — Manning, J. Vitamin C promotes maturation of T-cells. Marcus, S. Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cells.

Mayland, C. Vitamin C deficiency in cancer patients. Palliat Med. Mehdi, W. Investigation of the antioxidant status in multiple myeloma patients: effects of therapy. Cancer Prev. Mikirova, N. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. Modulation of cytokines in cancer patients by intravenous ascorbate therapy.

Mingay, M. Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia. Leukemia 32, 11— Minor, E. Ascorbate induces Ten-eleven translocation Tet methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.

Moertel, C. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. Monti, D. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

PLoS One 7:e Muhlhofer, A. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers. Murata, A. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate.

Vitam Nutr. Nannya, Y. Serial profile of vitamins and trace elements during the acute phase of allogeneic stem cell transplantation. Blood Marrow Transplant. Nielsen, T. Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial. Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: a pharmacokinetic evaluation.

Basic Clin. Oak, A. A case of scurvy associated with nilotinib. Cutan Pathol. Padayatty, S. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ , — Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5:e Vitamin C pharmacokinetics: implications for oral and intravenous use. Park, J. Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice.

Park, S. Cell Biochem. Parrow, N. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Polireddy, K. Pollard, H. Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer. In Vivo 24, — Pullar, J. Appropriate handling, processing and analysis of blood samples is essential to avoid oxidation of vitamin C to dehydroascorbic acid. Antioxidants 7:E Quinn, J. Effect of high-dose vitamin C infusion in a glucosephosphate dehydrogenase-deficient patient.

Case Rep. Ramaswamy, G. Serum carotene, vitamin A, and vitamin C levels in breast cancer and cancer of the uterine cervix. Cancer 25, — Rasheed, M. Low plasma vitamin C levels in patients undergoing stem cell transplantation Abstract.

Blood Marrow Transpl. Raymond, Y. Effects of high doses of vitamin C on cancer patients in singapore: nine cases. Rees, D. Acute haemolysis induced by high dose ascorbic acid in glucosephosphate dehydrogenase deficiency. BMJ , — Reuter, S. Oxidative stress, inflammation, and cancer: how are they linked? Riordan, H. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

PR Health Sci. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. Robitaille, L. Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism 58, — Rouleau, L. Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: new insights into ascorbate cytotoxicity. Savini, I. Amino Acids 34, — Schoenfeld, J. Cancer Cell. Seely, D. A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology.